Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain 2 year highlights at a glance

News
2 year anniversaryGate2Brain

This year, to commemorate the 2nd anniversary of our company, we published a corporate booklet summarizing Gate2Brain’s highlights in its first two years of life.

Looking at our publication and video, it both feels like a blink of an eye, and now here we’re! and at the same time like such a hard-earned milestone. They say when you start your business the first year is usually the hardest, and when your first year is 2020? Well, you get the picture!!

Launching Gate2Brain has been quite the roller coaster filled with rewarding highs and hard work times. Despite the tough times, one thing remains crystal clear, how grateful we’re to our team, founders, advisors, investors and collaborators. Their work, expertise and support are bringing us every day one step further to bring medicines beyond barriers.

While here we’re so proud of what our first two years have entailed, most of all, we’re highly motivated and excited about what the future will bring. Growth, challenges, highs and lows, we’ll welcome them with curiosity and enthusiasm.

We invite you to take a look over our first 2 years, our technology, our dream, our team, our highlights, to cut it short, the beginning of a challenging and rewarding journey towards bringing medicines beyond barriers. Enjoy it!

November 9, 2022/by noticias
Tags: anniversary, Gate2Brain, medicinesbeyondbarriers
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/11/Sin-Gate2Brain-2nd-anniversary-1.gif 1712 1210 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-11-09 10:27:182025-02-19 09:09:03Gate2Brain 2 year highlights at a glance
You might also like
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
Gate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022
Gate2Brain abre una ronda puenteo de un millón de euros para ensayos preclínicoPlantaDoceGate2Brain opens one million euro bridge round for preclinical trials
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
The future belongs to children: 3 startups that are changing their day to day
Patil Bhalchandra – Meet the Team

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gordon Research ConferencesGORDON CONFERENCESgate2braindesafio singaporeICEXDesafía Singapore
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}